A new imaging scan for advanced head and neck cancer
Part of Cancer clinical trials.
This trial tests an experimental PET scan that may help doctors see how well standard radiation and chemotherapy are working for advanced head and neck cancer. It aims to improve treatment planning by tracking a specific molecule in the body.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have advanced stage III or IV head and neck cancer in the throat (larynx, hypopharynx, or HPV-negative oropharynx).
- Your cancer cannot be removed with surgery (unresectable).
- You are planning to receive standard treatment with radiation (70 Gy over 7 weeks) plus weekly cisplatin chemotherapy.
- You are able to have special PET/CT scans before and after your treatment.
- Your overall health is good enough to tolerate the imaging and treatment.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a special PET/CT scan that may help doctors see the cancer more clearly in people with head and neck cancer, either at diagnosis or if it comes back.
This trial tests a new type of PET scan that uses a special tracer (68Ga-FAPI-46) to see if it can better show the extent of head and neck cancers before surgery. It may help doctors plan your treatment more accurately.
This trial tests a new imaging technique that uses a radioactive tracer to see how your cancer cells respond to DNA damage from treatment. The goal is to help doctors personalize your chemoradiation therapy by seeing if the treatment is working early on.
This trial is testing whether a newer type of PET/CT scan (F-18 NaF) can better detect blood vessel problems caused by radiation therapy than the standard scan (F-18 FDG) in people with head and neck cancer. If successful, it could lead to better ways to prevent and manage these complications.
This study tests a new radioactive tracer called [18F]NOTA-ABY030 to see if it's safe for people with head and neck cancer that may have spread. The tracer lights up cancer cells on a PET scan, helping doctors find tumors more clearly.
This study uses PET-CT scans (a type of imaging that highlights active cancer cells) in people with a specific kind of head and neck cancer. The goal is to see how well the first scan identifies tumors that should be checked again with a second scan, to better guide care with radiotherapy.
Hear when a new Locally Advanced Head and Neck Squamous Cell Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.